CompaniesAzur Pharma

Azur Pharma

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

136

By Phase

PHASE3: 1PHASE4: 1

By Status

COMPLETED: 2UNKNOWN: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Today

Hover over trial bars to see details

Recent Trials

NCT02979548Lead Sponsor

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

116 participants

Started: Nov 30, 2016 · Completed: Dec 31, 2018

NCT00501618Collaborator

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

PHASE4Completed

20 participants

Started: Nov 30, 2006 · Completed: Jul 31, 2009

NCT00683891Lead Sponsor

FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey

Funding History (3)

8-K

Jan 13, 2012

8-K

Jan 6, 2012

8-K

Dec 14, 2011

Related Companies

Jazz Pharmaceuticals

acquired